These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26817187)

  • 1. Bisphosphonate Therapy for Refractory Langerhans Cell Histiocytosis: A Case Report.
    Takpradit C; Vathana N; Narkbunnam N; Sanpakit K; Buaboonnam J
    J Med Assoc Thai; 2015 Nov; 98(11):1145-9. PubMed ID: 26817187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofarabine in refractory Langerhans cell histiocytosis.
    Rodriguez-Galindo C; Jeng M; Khuu P; McCarville MB; Jeha S
    Pediatr Blood Cancer; 2008 Nov; 51(5):703-6. PubMed ID: 18623218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Langerhans cell histiocytosis with pamidronate.
    Farran RP; Zaretski E; Egeler RM
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):54-6. PubMed ID: 11196272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
    Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
    Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
    Huang JB; Xue HM; Chen YY; Huang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate induces remission of refractory osteolysis in langerhans cell histiocytosis.
    Kamizono J; Okada Y; Shirahata A; Tanaka Y
    J Bone Miner Res; 2002 Nov; 17(11):1926-8. PubMed ID: 12412797
    [No Abstract]   [Full Text] [Related]  

  • 7. Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan.
    Morimoto A; Shioda Y; Imamura T; Kanegane H; Sato T; Kudo K; Nakagawa S; Nakadate H; Tauchi H; Hama A; Yasui M; Nagatoshi Y; Kinoshita A; Miyaji R; Anan T; Yabe M; Kamizono J;
    Pediatr Blood Cancer; 2011 Jan; 56(1):110-5. PubMed ID: 21108445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
    Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series.
    Sivendran S; Harvey H; Lipton A; Drabick J
    Int J Hematol; 2011 Jun; 93(6):782-786. PubMed ID: 21519845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
    Zhang XH; Zhang J; Chen ZH; Sai K; Chen YS; Wang J; Ke C; Guo CC; Chen ZP; Mou YG
    Ann Palliat Med; 2017 Apr; 6(2):159-164. PubMed ID: 28061539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent langerhans cell histiocytosis and B-lineage lymphoid proliferation in the bone marrow.
    Kim M; Kang HJ; Shin HY; Ahn HS; Lee DS
    Korean J Lab Med; 2009 Oct; 29(5):402-5. PubMed ID: 19893348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin.
    McCowage GB; Frush DP; Kurtzberg J
    J Pediatr Hematol Oncol; 1996 May; 18(2):154-8. PubMed ID: 8846128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vemurafenib in refractory langerhans histiocytosis].
    Raciborska A; Małas Z; Tysarowski A
    Dev Period Med; 2018; 22(4):376-378. PubMed ID: 30636236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis.
    Lockridge L; Papac RJ; Perazella MA
    Am J Kidney Dis; 2002 Jul; 40(1):E2. PubMed ID: 12087588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans' cell histiocytosis after living donor liver transplantation: report of a case.
    Honda R; Ohno Y; Iwasaki T; Okudaira S; Okada M; Kamitamari A; Ohshima K; Moriuchi H; Kanematsu T
    Liver Transpl; 2005 Nov; 11(11):1435-8. PubMed ID: 16237711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of bone lysis in Langerhans cell histiocytosis by bisphosphonate therapy.
    Tsuda H; Yamasaki H; Tsuji T
    Br J Haematol; 2011 Aug; 154(3):287. PubMed ID: 21595647
    [No Abstract]   [Full Text] [Related]  

  • 17. Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children.
    Uppuluri R; Ramachandrakurup S; Subburaj D; Bakane A; Raj R
    Pediatr Blood Cancer; 2017 Jan; 64(1):110-112. PubMed ID: 27555565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
    Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenalidomide proved effective in multisystem Langerhans cell histiocytosis.
    Szturz P; Adam Z; Rehák Z; Koukalová R; Slaisová R; Stehlíková O; Chovancová J; Klabusay M; Krejčí M; Pour L; Hájek R; Mayer J
    Acta Oncol; 2012 Mar; 51(3):412-5. PubMed ID: 22103591
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
    Apollonsky N; Lipton JM
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.